Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1973-04-25
1976-03-02
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 8, 424 12, 424 91, 23253TP, 252408, A61B 1000
Patent
active
039418766
ABSTRACT:
Allergic hypersensitivity to a large number of allergens is determined by coating narrow bands of an elongated body of cellulosic material with a large number of separate identified allergens. The coated bands are separated from each other by narrow allergen-free bands. The cellulosic body is then contacted with blood serum of the patient, washed and contacted with an anti-immunoglobulin E (IgE) specific antiserum labeled with either a fluorescent material or a radioactive material. The cellulosic body is again washed and bands containing fluorescent material or radioactive material are identified.
REFERENCES:
patent: 3443903 (1969-05-01), Haack
patent: 3549328 (1970-12-01), Kilburn
patent: 3838012 (1974-09-01), Higgens
"Immunochemistry", Vol. 4, pp. 11-22 (1967).
"The Journal of Immunology", Vol. 99, pp. 849-858.
"Int. Rev. Cytol.", Vol. 5, p. 1 (1956).
"Nature", Vol. 194, p. 495 (1962).
GTE New Ventures Corporation
Padgett Benjamin R.
Walsh Donald P.
LandOfFree
In vitro method for determining allergic hypersensitivity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In vitro method for determining allergic hypersensitivity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vitro method for determining allergic hypersensitivity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1278436